Home    Back

Hu mik-beta-1    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
26HTLV-1-associated myelopathy1

26. HTLV-1-associated myelopathy    [ 26 clinical trials,   46 drugs,   (DrugBank: 27 drugs),   37 drug target genes,   123 drug target pathways]
Searched query = "HTLV-1-associated myelopathy", "Tropical spastic paraparesis", "HTLV-1", "HTLV-I-associated myelopathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 26 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00076843
(ClinicalTrials.gov)		February 3, 200412/7/2006Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic ParaparesisPhase I Study of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Using the Humanized MiK-Beta-1 Monoclonal Antibody Directed Toward the IL-2L-15R-Beta; Subunit (CD122) That Blocks IL-15 ActionHTLV-1Drug: Hu MiK-Beta-1National Institute of Neurological Disorders and Stroke (NINDS)NULLCompleted18 YearsN/AAll9Phase 1United States